2021
DOI: 10.1016/j.jmoldx.2021.02.004
|View full text |Cite|
|
Sign up to set email alerts
|

Rapid Tuberculosis Diagnostics Including Molecular First- and Second-Line Resistance Testing Based on a Novel Microfluidic DNA Extraction Cartridge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…For the identification of the analytical sensitivity, the pathogenic MTBC strain H37Rv (ATCC, Manassas, VA;35829) was spiked in TB negative tested human sputum with real colony count correction of the bacteria concentration similar to previous studies. 20,40…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…For the identification of the analytical sensitivity, the pathogenic MTBC strain H37Rv (ATCC, Manassas, VA;35829) was spiked in TB negative tested human sputum with real colony count correction of the bacteria concentration similar to previous studies. 20,40…”
Section: Methodsmentioning
confidence: 99%
“…For the identification of the analytical sensitivity, the pathogenic MTBC strain H37Rv (ATCC, Manassas, VA;35829) was spiked in TB negative tested human sputum with real colony count correction of the bacteria concentration similar to previous studies. 20,40 Diagnostic sensitivity and specificity. The diagnostic sensitivity was determined with bacteriologically confirmed, randomly selected, microscopically positive sputum samples from TB patients in Nepal at the German Nepal TB Project (GENETUP) in Kalimati, Kathmandu-Valley, Nepal.…”
Section: Sample Collection and Descriptionmentioning
confidence: 99%
See 2 more Smart Citations
“…The availability of two identical DNA extracts significantly increased the versatility of the diagnostic workflow. 215 Kaur et al proposed a low-cost hybrid paper/plastic device for LAMP-based TB assays on 12 test zones. The chip features an array of sealed paper pads as amplification sites with dry-stored reagents and fluorescence smartphone read-out.…”
Section: Respiratory Tract Infectionsmentioning
confidence: 99%